Analysis of the potential effect of ponatinib on the QTc interval in patients with refractory hematological malignancies

Daryl Sonnichsen, David J. Dorer, Jorge Cortes, Moshe Talpaz, Michael W. Deininger, Neil P. Shah, Hagop M. Kantarjian, Dale Bixby, Michael J. Mauro, Ian W. Flinn, Jeffrey Litwin, Christopher D. Turner, Frank G. Haluska